The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis

OBJECTIVES: The mammalian target of Rapamycin (mTOR) is a metabolic master regulator of both innate and adaptive immunity; however, its exact role in stromal cell biology is unknown. In this study we explored the role of the mTOR pathway on Rheumatoid Arthritis synovial fibroblast (RASF) metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Barker, Brianne E., Hanlon, Megan M., Marzaioli, Viviana, Smith, Conor M., Cunningham, Clare C., Fletcher, Jean M., Veale, Douglas J., Fearon, Ursula, Canavan, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936094/
https://www.ncbi.nlm.nih.gov/pubmed/36817783
http://dx.doi.org/10.3389/fmed.2023.1029021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936094/
https://www.ncbi.nlm.nih.gov/pubmed/36817783
http://dx.doi.org/10.3389/fmed.2023.1029021

Ejemplares similares